Novo Integrated Sciences Inc. [NVOS] is -9.20% lower this YTD. Is it still time to buy?

Novo Integrated Sciences Inc. [NASDAQ: NVOS] stock went on a downward path that fall over -9.20% on Tuesday, amounting to a one-week price decrease of less than -9.11%. The company report on December 21, 2022 that Novo Integrated Sciences Announces Receipt of Notice from Nasdaq.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored


Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today reported that it received a notice (the “Notice) on December 15, 2022 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (the “Form 10-K”).

Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice or until February 13, 2023, to submit a plan to regain compliance with the Rule. If Nasdaq accepts the Company’s plan, then Nasdaq may grant an exception of up to 180 calendar days from the due date of the Form 10-K, or until June 12, 2023, to regain compliance.

Over the last 12 months, NVOS stock dropped by -86.96%.

The market cap for the stock reached $5.63 million, with 29.82 million shares outstanding and 12.54 million shares in the current float. Compared to the average trading volume of 252.64K shares, NVOS stock reached a trading volume of 12787472 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Novo Integrated Sciences Inc. [NVOS]:

The Average True Range (ATR) for Novo Integrated Sciences Inc. is set at 0.03, with the Price to Sales ratio for NVOS stock in the period of the last 12 months amounting to 0.25. The Price to Book ratio for the last quarter was 0.12, with the Price to Cash per share for the same quarter was set at 0.41.

NVOS Stock Performance Analysis:

Novo Integrated Sciences Inc. [NVOS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.11. With this latest performance, NVOS shares dropped by -28.56% in over the last four-week period, additionally sinking by -90.08% over the last 6 months – not to mention a drop of -86.96% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NVOS stock in for the last two-week period is set at 27.94, with the RSI for the last a single of trading hit 25.13, and the three-weeks RSI is set at 28.36 for Novo Integrated Sciences Inc. [NVOS]. The present Moving Average for the last 50 days of trading for this stock 0.2395, while it was recorded at 0.1957 for the last single week of trading, and 1.3941 for the last 200 days.

Insight into Novo Integrated Sciences Inc. Fundamentals:

Novo Integrated Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 1.60.

Novo Integrated Sciences Inc. [NVOS] Insider Position Details

There are presently around $0 million, or 1.40% of NVOS stock, in the hands of institutional investors. The top three institutional holders of NVOS stocks are: VANGUARD GROUP INC with ownership of 255,940, which is approximately 0% of the company’s market cap and around 59.78% of the total institutional ownership; ROYAL BANK OF CANADA, holding 78,296 shares of the stock with an approximate value of $14000.0 in NVOS stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $5000.0 in NVOS stock with ownership of nearly 0% of the company’s market capitalization.

3 institutional holders increased their position in Novo Integrated Sciences Inc. [NASDAQ:NVOS] by around 29,445 shares. Additionally, 3 investors decreased positions by around 9,516 shares, while 3 investors held positions by with 405,620 shares. The mentioned changes placed institutional holdings at 444,581 shares, according to the latest SEC report filing. NVOS stock had 1 new institutional investments in for a total of 23,381 shares, while 0 institutional investors sold positions of 0 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here